Shen et al. showed that CCR3 monoclonal antibody significantly inhibited airway eosinophilia and mucus overproduction in asthmatic mice, indicating that blockage of CCR3 may represent a new strategy for asthma treatment [27]. This evidence concerns the gene CCR3 and Increased total eosinophil count.